FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

432886002: Sorafenib tosylate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2741866016 Sorafenib tosylate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2766651014 Sorafenib tosylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2741866016 Sorafenib tosylate (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2741866016 Sorafenib tosylate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2766651014 Sorafenib tosylate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2766651014 Sorafenib tosylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
841711000172111 tosylate de sorafénib fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
841711000172111 tosylate de sorafénib fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sorafenib tosylate (substance) Is a Sorafenib false Inferred relationship Existential restriction modifier (core metadata concept)
Sorafenib tosylate (substance) Has disposition Angiogenesis inhibitor (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Sorafenib tosylate (substance) Has disposition Protein-tyrosine kinase inhibitor (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Sorafenib tosylate (substance) Is a Pyridine true Inferred relationship Existential restriction modifier (core metadata concept)
Sorafenib tosylate (substance) Is a Angiogenesis inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Sorafenib tosylate (substance) Is a Protein-tyrosine kinase inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Sorafenib tosylate (substance) Is modification of (attribute) Sorafenib true Inferred relationship Existential restriction modifier (core metadata concept)
Sorafenib tosylate (substance) Is a Enzyme inhibitor false Inferred relationship Existential restriction modifier (core metadata concept)
Sorafenib tosylate (substance) Is a Antineoplastic agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Sorafenib tosylate (substance) Has disposition Vascular endothelial growth factor receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Sorafenib tosylate (substance) Is a Vascular endothelial growth factor receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Sorafenib tosylate (substance) Is a Phenylurea compound (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely sorafenib (as sorafenib tosylate) 200 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sorafenib tosylate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely sorafenib (as sorafenib tosylate) 200 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sorafenib tosylate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely sorafenib (as sorafenib tosylate) 200 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Sorafenib tosylate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start